Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer’s Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects

Butyrylcholinesterase K Variant and Alzheimer’s Disease Risk: A Meta-Analysis

(2015) Jinlian Wang   MEDICAL SCIENCE MONITOR

Butyrylcholinesterase K and Apolipoprotein ε4 Affect Cortical Thickness and Neuropsychiatric Symptoms in Alzheimer’s Disease

(2014) Hye Yoo et al.   Current Alzheimer Research

APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease

(2013) Yu-Ling Chang et al.   Alzheimers & Dementia

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

(2013) V K Ramanan et al.   MOLECULAR PSYCHIATRY

Butyrylcholinesterase genotype and gender influence Alzheimer’s disease phenotype

(2012) Roger M. Lane et al.   Alzheimers & Dementia

Association analysis between K and −116A variants of butyrylcholinesterase and Alzheimer’s disease in a Brazilian population

(2012) Daiane Priscila Simão-Silva et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Genetic insights in Alzheimer's disease

(2012) Karolien Bettens et al.   LANCET NEUROLOGY

BuChE K variant is decreased in Alzheimer’s disease not in fronto-temporal dementia

(2010) Alessandra Bizzarro et al.   JOURNAL OF NEURAL TRANSMISSION

The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology♦

(2009) Erez Podoly et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regional atrophy of transcallosal prefrontal connections in cognitively normalAPOEϵ4 carriers

(2009) Nicola Filippini et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE ε4, and hyperhomocysteinemia in neurodegenerative dementias

(2009) Roger M. Lane et al.   MEDICAL HYPOTHESES

Synergistic effect of apolipoprotein E ϵ4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimerʼs disease

(2009) Roger Lane et al.   Pharmacogenetics and Genomics

Effect of ApoE Genotype on Response to Donepezil in Patients with Alzheimer’s Disease

(2008) Seong Hye Choi et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Gene–gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk

(2008) I. Mateo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

(2008) Raj N Kalaria et al.   LANCET NEUROLOGY

BuChE-K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline

(2008) Roger Lane et al.   MOVEMENT DISORDERS

Human Recombinant Butyrylcholinesterase Purified from the Milk of Transgenic Goats Interacts with Beta-Amyloid Fibrils and Suppresses Their Formation in vitro

(2008) E. Podoly et al.   Neurodegenerative Diseases